| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9701374.2AGB9701374D0 (en) | 1997-01-23 | 1997-01-23 | Purinergic agonists and antagonists |
| AU56747/98AAU5674798A (en) | 1997-01-23 | 1998-01-23 | P2 receptor agonists, antagonists and modulators of endogenous atp release |
| PCT/GB1998/000205WO1998032429A2 (en) | 1997-01-23 | 1998-01-23 | P2 receptor agonists, antagonists and modulators of endogenous atp release for the treatment of skin conditions and the improvement of wound healing |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9701374.2AGB9701374D0 (en) | 1997-01-23 | 1997-01-23 | Purinergic agonists and antagonists |
| Publication Number | Publication Date |
|---|---|
| GB9701374D0true GB9701374D0 (en) | 1997-03-12 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB9701374.2APendingGB9701374D0 (en) | 1997-01-23 | 1997-01-23 | Purinergic agonists and antagonists |
| Country | Link |
|---|---|
| AU (1) | AU5674798A (en) |
| GB (1) | GB9701374D0 (en) |
| WO (1) | WO1998032429A2 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0120704D0 (en)* | 2000-09-01 | 2001-10-17 | Glaxo Group Ltd | Polypeptide |
| FR2826278B1 (en)* | 2001-06-20 | 2005-03-25 | Lipha | USE OF ANTIDIABETIC AGENTS FOR MANUFACTURING A MEDICAMENT HAVING A HEALING EFFECT |
| AU2002319381A1 (en)* | 2001-06-20 | 2003-01-21 | Merck Sante | Use of antidiabetics for making a medicine with cicatrizing effect |
| JP4627988B2 (en)* | 2002-04-09 | 2011-02-09 | 大塚製薬株式会社 | Composition for cell proliferation |
| EP1610783A2 (en)* | 2003-03-27 | 2006-01-04 | Medicure Inc. | Modulation of cell death |
| US7557093B2 (en) | 2003-10-08 | 2009-07-07 | Otsuka Pharmaceutical Co., Ltd. | Composition for promoting collagen production |
| ATE509623T1 (en) | 2004-06-28 | 2011-06-15 | Ajinomoto Kk | NUTRIENT COMPOSITION AND COMPOSITION FOR PREVENTION/MITIGATION OF DIGESTIVE TRACT DEPRESSION |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2844103B2 (en)* | 1990-02-09 | 1999-01-06 | 株式会社コーセー | External preparation for skin |
| Publication number | Publication date |
|---|---|
| WO1998032429A2 (en) | 1998-07-30 |
| WO1998032429A3 (en) | 1999-04-01 |
| AU5674798A (en) | 1998-08-18 |
| Publication | Publication Date | Title |
|---|---|---|
| HUP0002373A3 (en) | Glucagon antagonists/inverse agonists | |
| IL139136A0 (en) | Il-2 selective agonists and antagonists | |
| HUP0102535A3 (en) | Cd19xcd3 specific polypeptides and uses thereof | |
| EP1032377A4 (en) | Substituted 2-aminoacetamides and the use thereof | |
| IL130660A0 (en) | Benzothiophenecarboxamide derivatives and PGD2 antagonists comprising them | |
| EP0977751A4 (en) | Somatostatin agonists | |
| ZA974147B (en) | Somatostatin agonists and antagonists. | |
| IL132303A0 (en) | Gnrh antagonists being modified in positions 5 and 6 | |
| EP1016480A4 (en) | Shank fitting structure | |
| PL346247A1 (en) | Muscarinic agonists and antagonists | |
| IL132903A0 (en) | N-triazolyl-2-indolecarboxamides and their their use as cck-a agonists | |
| GB9820014D0 (en) | Receptor antagonists and uses thereof | |
| HUP0004317A3 (en) | 5-ht1f agonists | |
| GB9701374D0 (en) | Purinergic agonists and antagonists | |
| HUP0104723A3 (en) | New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use | |
| IL123535A0 (en) | Benzoxazindione derivatives and their use | |
| PL307138A1 (en) | Amyline antagonists and agonists | |
| ZA984896B (en) | Carbohydrates and use thereof | |
| GB9722392D0 (en) | Composition and use | |
| ZA985759B (en) | Glucagon antagonists/inverse agonists | |
| ZA988065B (en) | Pyrimidin-2-oxy-4-one and pyrimidin-2-oxy-4-thione derivatives | |
| AUPP058597A0 (en) | Receptor agonists and antagonists | |
| GB9722390D0 (en) | Composition and use | |
| GB9712961D0 (en) | Composition and use | |
| GB9715323D0 (en) | Piperidinecarboxamides and their use |